Matches in Nanopublications for { ?s ?p "[NAT2 (arylamine N-acetyltransferase 2) polymorphism, being a key determinant of individual variations in acetylation capacity, is suspected to modify the risk of carcinogen-related malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- NP367077.RAFqGwVA89LANwzjYmD8AsbJfvo2IroV3kDrMJCTm2mL0130_assertion description "[NAT2 (arylamine N-acetyltransferase 2) polymorphism, being a key determinant of individual variations in acetylation capacity, is suspected to modify the risk of carcinogen-related malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP367077.RAFqGwVA89LANwzjYmD8AsbJfvo2IroV3kDrMJCTm2mL0130_provenance.